Skip to main content

POWER2DM - Predictive model-based decision support for diabetes patient empowerment

Objective

The main objective of POWER2DM is to develop and validate a personalized self-management support system (SMSS) for T1 and T2 diabetes patients that combines and integrates (1) a decision support system (DSS) based on leading European predictive personalized models for diabetes interlinked with predictive computer models, (2) automated e-coaching functionalities based on Behavioural Change Theories, and (3) real-time Personal Data processing and interpretation.
The DSS will be based on the complementary combination of proven predictive models for short term plasma glucose prediction, medium term diabetes progression, and long term risk scoring for diabetes complications. These models will be integrated in adaptive personalized behavior change interventions to increase adherence of the patients to their care program and improve their interaction with health professionals. A cloud-based Data Integration Service, collecting and processing data from personal devices and EHR/PHR in real-time feeds the DSS.
The results of the SMSS with respect to clinical parameters, awareness, acceptance and empowerment of the patient to participate in the care process will be evaluated in three studies in NL, DE and ES.
The deliverables of the project will increase self-management capabilities and participation of the patient in the care process, resulting in better self-control and management of the disease. This will lead to better glucose management, thereby preventing severe episodes and long-term complications. POWER2DM will reinforce the prevention sector in healthcare by raising the acceptance of SMSS based on DSS that use predictive models fed by data from personal devices. POWER2DM will challenge individuals towards more frequent and long-term use of personal devices for self-monitoring, boosting the development of these devices. POWER2DM will thereby make an essential step forward in empowering the patient, advancing prevention and decreasing disease burden and costs.

Field of science

  • /medical and health sciences/clinical medicine/endocrinology/diabetes

Call for proposal

H2020-PHC-2015-single-stage
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO
Address
Anna Van Buerenplein 1
2595 DA Den Haag
Netherlands
Activity type
Research Organisations
EU contribution
€ 1 071 743,33

Participants (7)

INSTITUT FUR DIABETES GERHARDT KATSCH KARLSBURG EV
Germany
EU contribution
€ 483 785,90
Address
Greifswalder Strasse 11E
17495 Karlsburg
Activity type
Research Organisations
SRDC YAZILIM ARASTIRMA VE GELISTIRME VE DANISMANLIK TICARET ANONIM SIRKETI
Turkey
EU contribution
€ 640 400
Address
Silikon Bina 1 Kat No 14 Odtu Teknokent Cankaya
06800 Ankara
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ACADEMISCH ZIEKENHUIS LEIDEN
Netherlands
EU contribution
€ 888 239,33
Address
Albinusdreef 2
2333 ZA Leiden
Activity type
Higher or Secondary Education Establishments
SERVICIO ANDALUZ DE SALUD
Spain
EU contribution
€ 505 155,19
Address
Avenida De La Constitucion 18
41071 Sevilla
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SALZBURG RESEARCH FORSCHUNGSGESELLSCHAFT M.B.H.
Austria
EU contribution
€ 581 000
Address
Jakob Haringer Strasse 5
5020 Salzburg
Activity type
Research Organisations
PRIME DATA B.V.
Netherlands
EU contribution
€ 412 470
Address
Olof Palmestraat 16 T/m 18
2616LR Delft
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
IHEALTHLABS EUROPE
France
EU contribution
€ 398 760
Address
36 Rue De Ponthieu
75008 Paris
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)